Mr Marcus Cumberbatch

Consultant urological surgeon in Nottinghamshire & Sheffield

MBBS PhD MSc BSc FRCS (Urol)

GMC: 7021039

43 Patient reviews Review the doctor

Watch video introduction

Call

Book online

e-Consultation

Call

Book online

e-Consultation

Mr Marcus Cumberbatch areas of expertise:

Professional statement

Mr Marcus Cumberbatch is a leading consultant urological surgeon based in Sheffield and Nottingham, who specialises in prostate cancer, medicolegal work and prostate biopsy alongside bladder problems, benign prostate enlargement, kidney cancer and adult circumcision. He privately practises at The Thornbury Hospital, Spire Hospital Claremont and The Park Hospital, while his NHS base is Royal Hallamshire Hospital. He is also the Cancer Lead of the directorate.

Mr Cumberbatch has an impressive educational CV, with an MBBS from University College London and MRCS from the Royal College of Surgeons of England. As part of his medical school training, Mr Cumberbatch attended the Welcome Institute where he obtained a scholarship to complete an Intercalated BSc in the History of Medicine.

Further educational achievements include foundation training in the Nottingham Deanery, the Academic Clinical Fellowship and a PhD in Cancer Biology. He was also awarded an Academic Clinical Lectureship by the National Institute for Health Research (NIHR) and was granted the Ellison-Cliffe Foundation Award by the Royal Society of Medicine (RSM) where he learnt about robot-assisted surgery and novel cancer diagnostics in Melbourne, Australia.

Mr Cumberbatch is also highly experienced in the medicolegal aspects of urological surgery, preparing expert opinion reports on a wide range of conditions, including prostate, testicular, bladder, and kidney issues. He completes 4 to 8 reports per month, with an average turnaround of four weeks, and undertakes cases involving clinical negligence and personal injury. His expertise covers screening, breach of duty, causation, condition and prognosis reports.

While he primarily represents claimants, he also has experience with defendant cases and has provided oral evidence at Family and Coroners counsel meetings. He is committed to ensuring his reports meet the court's requirements, adhering to his duty of impartiality and accuracy. Mr Cumberbatch's medicolegal practice is underpinned by his extensive clinical experience, encompassing robotic, laparoscopic, and open surgical techniques, alongside his completion of the Royal Society of Medicine's legal day.

Mr Cumberbatch is highly respected among his peers, and he has presented at various international conferences in countries including Japan, Spain and Denmark. He holds several leadership positions including principal investigator on a number of NIHR portfolio clinical trials investigating the use of robotics in minimally-invasive surgery, patient outcome meetings and cancer screening.

His clinical research has featured in a selection of peer-reviewed journals, and he has an international reputation for his cancer epidemiology knowledge. Mr Cumberbatch is a member of various professional organisations, including the European Association of Urology (EAU) and the Medical Defence Union (MDU). Furthermore, he's a fellow of the Royal College of Surgeons of Edinburgh.

In 2021, Mr Cumberbatch published an international multicentre series showing that robotic surgery can be used even in high-risk situations where kidney function is poor or only one kidney is present. These patients previously may have been facing open surgery or lifelong dialysis, but with robotic techniques can now be offered a keyhole operation to remove the cancer with less complications, faster recovery, and preserved kidney function.

Reviews

Treatments

Articles

Download

Images

Videos

Videos of doctor

Patient testimonial for Mr Marcus Cumbe...

View all videos by Mr Marcus Cumberbatch

Doctor's articles

Your guide to medicolegal work in negli...

Read all articles by Mr Marcus Cumberbatch

Credentials

GMC: ‍7021039

Professional experience

• More than 5 years of experience
• Consultant urological surgeon, Spire Hospital Claremont (Present)
• Consultant urological surgeon, The Park Hospital (Present)
• Consultant urological surgeon, The Thornbury Hospital (Present)
• Consultant urological surgeon, Royal Hallamshire Hospital (Present)
• Senior clinical lecturer, University of Sheffield (Present)

...

Sub-specialties

• Benign prostate disease
• Bladder lesion removal
• Blue light cystoscopy (bladder scope)
• Cancer surgery
• Cancer treatments
• Cystoscopy (flexible)
• Hydrocele repair
• Kidney cancer treatment
• Laparoscopy nephrectomy
• Kidney removal
• Prostate cancer - prostatectomy
• Prostate surgery
• Rigid cystoscopy (bladder scope)
• Robotic prostatectomy
• Saturation biopsies of the prostate
• Surgery for benign scrotal lumps
• Testicular cancer
• Transurethral resection of a bladder tumour (TURBT)
• Transurethral resection of the prostate (TURP)
• Lower urinary tract symptoms
• Ureteroscopy (rigid and flexible)
• Urinary tract infection (UTI)
• Vasectomy (bilateral)

...

Teaching posts

• Senior clinical lecturer, University of Sheffield

Education

• FRCS (Urol), Royal College of Surgeons of Edinburgh (May 2019)
• MRCS (Lon), The Royal College of Surgeons of England (February 2011)
• MBBS, University College London (2002 - 2008)
• Intercalated BSc, History of Medicine
• PhD, Cancer Biology

...

Publications and conferences

• Viphakone N, Cumberbatch MG, Livingstone M, Catto J, Heath P.R, Dickman M, Wilson S.A. Luz
p4 defines a new mRNA export pathway in cancer cells.
Nucleic Acids Research.
2015 Feb 27;43(4):2353-66.
• Cumberbatch MG, Rota M, Catto JW, La Vecchia C.
The Role of Tobacco Smoke in Bladder and Kidney Carcinogenesis: A Comparison of Exposures and Meta-analysis of Incidence and Mortality Risks.
Eur Urol.
2015 Jul 3. pii: S0302-2838(15)00548-5.
• Cumberbatch MG, Cox A, Tear D, Catto JWF.
Contemporary occupational bladder cancer: A systematic review and meta-analysis.
JAMA Onc.
2015 Dec;1(9):1282-90.
• Cumberbatch MG, Catto JW.
Micropapillary Variant Bladder Cancer: A Bad Apple or a New Fruit?
Eur Urol.
2016 Apr 29.
• Cumberbatch MG, Windsor-Shellard B, Catto JW.
The contemporary landscape of occupational bladder cancer within the United Kingdom: a meta-analysis of risks over the last 80 years.
BJU Int.
2016 Jun 22.
• Cumberbatch MG, Catto JW.
The use of biomarkers to manage men with metastatic prostate cancer: One day, but not yet..
Eur Urol Focus.
2016 Dec;2(5):467-468.
• Moldovan PC, Van den Broeck T, Sylvester R, Marconi L, Bellmunt J, van den Bergh RC, Bolla M, Briers E, Cumberbatch MG, Fossati N, Gross T, Henry AM, Joniau S, van der Kwast TH, Matveev VB, van der Poel HG, De Santis M, Schoots IG, Wiegel T, Yuan CY, Cornford P, Mottet N, Lam TB, Rouvière O.
What Is the Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in Excluding Prostate Cancer at Biopsy?
A Systematic Review and Meta-analysis from the European Association of Urology Prostate Cancer Guidelines Panel. Eur Urol.
2017 Mar 20
• Bourke L, Bauld L, Bullen C, Cumberbatch M, Giovannucci E, Islami F, McRobbie H, Silverman DT, Catto JWF.
E-cigarettes and Urologic Health: A Collaborative Review of Toxicology, Epidemiology, and Potential Risks.
Eur Urol.
2017 Jun;71(6):915-923
• Lardas M, Liew M, van den Bergh RC, De Santis M, Bellmunt J, Van den Broeck T, Cornford P, Cumberbatch MG, Fossati N, Gross T, Henry AM, Bolla M, Briers E, Joniau S, Lam TB, Mason MD, Mottet N, van der Poel HG, Rouvière O, Schoots IG, Wiegel T, Willemse PM, Yuan CY, Bourke L.
Quality of Life Outcomes after Primary Treatment for Clinically Localised Prostate Cancer: A Systematic Review.
Eur Urol.
2017 Jul 27.
• Van den Broeck T, van den Bergh RCN, Arfi N, Gross T, Moris L, Briers E, Cumberbatch M, De Santis M, Tilki D, Fanti S, Fossati N, Gillessen S, Grummet JP, Henry AM, Lardas M, Liew M, Rouvière O, Pecanka J, Mason MD, Schoots IG, van Der Kwast TH, van Der Poel HG, Wiegel T, Willemse PM, Yuan Y, Lam TB, Cornford P, Mottet N.
Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review..
Eur Urol.
2018 Oct 17.pii: S0302-2838(18)30752-8.

...

Prizes and awards

• Merit of Achievement for First Year Finals Examinations. Awarded for being in the 90th Centile. University College London, UK (2003)
• The Royal College of Psychiatry Medical Student Electives grant prize for elective research project (2008)
• SURG Urology Poster Prize at the Association of Surgeons in Training (ASiT) conference, Cardiff, UK (Mar 2012)
• YUAG (Yorkshire Urology Audit Group/BAUS meeting), Gordon Bryden Medal for overall best audit presentation and Q&A, Leeds, UK. Nov 2012.
• ‘BiotechYes’, Young entrepreneurs in science workshop and competition, Runners Up, Manchester (Oct 2014)
• BAUS Academic Urology, Session 1, Poster Prize: mRNA and Cancer, Royal College of Surgeons of England (Dec 2014)
• The Hunterian Professorship, Royal College of Surgeons of England (2023)

...

Professional membership

• European Association of Urology (EAU)
• Medical Defence Union (MDU)

Languages spoken

English